Veeva Q4 operating income jumps 30% to USD 245.9 million

Reuters05:04
Veeva Q4 operating income jumps 30% to USD 245.9 million

Veeva reported Q4 FY2026 total revenues of USD 836.0 million (up 16%) and subscription revenues of USD 707.7 million (up 16%). Q4 operating income was USD 245.9 million (up 30%) and net income was USD 244.2 million (up 25%), with fully diluted EPS of USD 1.45; non-GAAP operating income was USD 366.5 million (up 19%) and non-GAAP net income was USD 346.1 million (up 20%), with non-GAAP fully diluted EPS of USD 2.06. For FY2026, Veeva posted total revenues of USD 3.2 billion (up 16%) and subscription revenues of USD 2.7 billion (up 17%). FY operating income was USD 916.4 million (up 33%) and net income was USD 908.9 million (up 27%), with fully diluted EPS of USD 5.44; non-GAAP operating income was USD 1.4 billion (up 24%) and non-GAAP net income was USD 1.4 billion (up 24%), with non-GAAP fully diluted EPS of USD 8.10. In business updates, Veeva ended the year with 1,552 customers, including 1,196 in R&D and Quality Solutions and 767 in Commercial Solutions, and said it achieved a USD 3 billion revenue run rate in early 2025. The company highlighted progress with Veeva AI Agents for CRM and commercial content, with several customers live and more projects underway, and said it expects to release additional agents across other major application areas throughout 2026. Veeva also reported Vault CRM adoption with more than 125 customers live, 10 of the top 20 biopharmas committed globally, and expects about 14 of the top 20 to commit; it also cited momentum in Development Cloud and Quality Cloud, including a top 20 biopharma selecting Veeva RTSM as its enterprise standard and progress toward a first top 20 biopharma go-live for Veeva LIMS at two manufacturing sites in 2026. For outlook, Veeva guided Q1 FY2027 total revenues of USD 855 million to USD 858 million and updated FY2027 total revenues guidance to USD 3.6 billion to USD 3.6 billion, alongside non-GAAP operating income of about USD 1.6 billion and non-GAAP fully diluted EPS of approximately USD 8.85.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001393052-26-000007), on March 04, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment